Inside the mountain where engineering ambition shapes the energy landscape

Drax Group plc

Deep within the granite of Ben Cruachan lies a project that was once dismissed as too ambitious, too bold for its time. Sixty years on, the same site is not only still operating but has become a rare blend of infrastructure, community anchor, and strategic asset.

What makes Cruachan different is not just the scale but the originality of its design. Conceived in the 1930s but only realised decades later, the scheme carved out a machine hall inside the mountain itself, with turbines capable of shifting water from a high reservoir back into Loch Awe almost instantly.

At its peak, the construction demanded a workforce of 1,500, removing more than 200,000 square metres of rock to create chambers of cathedral-like dimensions. When it opened in 1965, it was the first reversible pumped storage station of its scale anywhere in the world.

Drax acquired the asset from ScottishPower in 2018 and is now investing £80 million to ensure its long-term role in the energy system.

Drax Group plc (LON:DRX), trading as Drax, is a power generation business. The principal downstream enterprises are based in the UK and include Drax Power Limited, which runs the biomass fuelled Drax power station, near Selby in North Yorkshire.

Share on:
Find more news, interviews, share price & company profile here for:

    Fidelity Emerging Markets Ltd outperforms index buoyed by stocks in Brazil, Taiwan and China

    Fidelity Emerging Markets has published its monthly factsheet for August 2025. The Trust reported positive returns, outperforming its benchmark, with stock selection in Brazil, Taiwan and China adding value.

    Fidelity Special Values strong performance reinforces attractiveness of UK equities  

    Fidelity Special Values sees strong 12-month gains as UK equities quietly reward contrarian investors amid persistent capital outflows.

    Fidelity European Trust rises in August, reporting 16.4% returns in 2025

    Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

    Real Estate Credit Investments extends share buybacks up to £10 million

    Real Estate Credit Investments has extended its share buyback programme to 31 March 2026 with a limit of up to £10 million. Since the launch of its first programme in 2023, the Company has repurchased over 7.6 million shares for £9.4 million.

    Cizzle Biotechnology US Rollout Begins as Lung Cancer Test Moves from Lab to Clinic (Video)

    Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand.

      Search

      Search